FDA Import Refusal 8B4-0011359-1/80002/1D — E.B. Pharmaceutical Ltd.
The FDA refused shipment 8B4-0011359-1/80002/1D from E.B. Pharmaceutical Ltd. (Ghana) on Jan 2, 2026. The refused product falls under Drugs and Biologics — SILVER SULFADIAZINE (ANTI-INFECTIVE, TOPICAL). Cited charges: 118,3280
Refusal details
- Date
- Jan 2, 2026
- Country
- Ghana
- Product Category
- Drugs and Biologics
- Product Code
- 62FCJ38 SILVER SULFADIAZINE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 118,3280